Quick Answer
SYNAPTICS Inc reported R&D Expense of $346.80 million for fiscal year 2025.
SYNAPTICS Inc R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $346.80M | +3.1% |
| 2024 | $336.30M | -4.2% |
| 2023 | $351.20M | -4.4% |
| 2022 | $367.30M | +17.2% |
| 2021 | $313.40M | +3.6% |
| 2020 | $302.50M | -11.7% |
| 2019 | $342.70M | -5.6% |
| 2018 | $363.20M | +24.3% |
| 2017 | $292.30M | -6.1% |
| 2016 | $311.20M | +6.1% |
| 2015 | $293.20M | +52.2% |
| 2014 | $192.70M | +33.2% |
| 2013 | $144.70M | +22.7% |
| 2012 | $117.95M | +12.3% |
| 2011 | $105.00M | +21.3% |
| 2010 | $86.55M | +27.2% |
| 2009 | $68.03M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $95.10M | +14.2% | +0.7% |
| September 30, 2025 | $94.40M | +16.1% | +6.5% |
| March 31, 2025 | $88.60M | +6.2% | +6.4% |
| December 31, 2024 | $83.30M | +1.6% | +2.5% |
| September 30, 2024 | $81.30M | -6.0% | -2.5% |
| March 31, 2024 | $83.40M | -5.1% | +1.7% |
| December 31, 2023 | $82.00M | -8.2% | -5.2% |
| September 30, 2023 | $86.50M | -3.4% | -1.6% |
- SYNAPTICS Inc showed an increase of +3.1% in R&D Expense compared to the prior fiscal year.
- Over the 2009–2025 period, SYNAPTICS Inc’s r&d expense has grown by 409.8% (from $68.03 million to $346.80 million).
- The most recent figure is from SYNAPTICS Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on August 21, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: